5526 - 5550 of 6568 Results
Title
Year
-
OPENTitle: Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutationsJournal Name: Bioscience ReportsPublisher: Portland Press Ltd.Vol: 35Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bsr20150128Best OA location URL: https://portlandpress.com/bioscirep/article-pdf/35/5/e00254/477473/bsr035e254.pdfCitation Count: 27
-
OPENTitle: Identifying blood-brain-barrier selective single-chain antibody fragmentsJournal Name: Biotechnology JournalPublisher: WileyVol: 9Issue #: 5Start Page: 664End Page: 674Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/biot.201300550Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4073886Citation Count: 23
-
OPENTitle: Synthesis and SAR of a novel positive allosteric modulator (PAM) of the metabotropic glutamate receptor 4 (mGluR4)Journal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 19Issue #: 17Start Page: 4967End Page: 4970Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2009.07.072Best OA location URL: http://doi.org/10.1016/j.bmcl.2009.07.072Citation Count: 38
-
OPENTitle: SNCA Variant Associated With Parkinson Disease and Plasma α-Synuclein LevelJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 67Issue #: 11Start Page: 1350End Page: 6Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2010.279Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3010848Citation Count: 178
- Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques2013OPENTitle: Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaquesJournal Name: Annals of NeurologyPublisher: WileyVol: 74Issue #: 4Start Page: 602End Page: 610Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.23939Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3800272Citation Count: 40
-
OPENTitle: N‐acetylcysteine prevents loss of dopaminergic neurons in the EAAC1−/− mouseJournal Name: Annals of NeurologyPublisher: WileyVol: 69Issue #: 3Start Page: 509End Page: 520Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.22162Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.22162Citation Count: 138
- Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.2013OPENTitle: Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.Journal Name: Anti-Inflammatory & Anti-Allergy Agents in Medicinal ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 12Issue #: 2Start Page: 117End Page: 128Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1871523011312020003Citation Count: 28
-
OPENTitle: The Relationship Between Mobility Dysfunction Staging and Global Cognitive PerformanceJournal Name: Alzheimer Disease & Associated DisordersPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 30Issue #: 3Start Page: 230End Page: 236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wad.0000000000000136Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4970960Citation Count: 33
-
OPENTitle: GBA mutations are associated with Rapid Eye Movement Sleep Behavior DisorderJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 2Issue #: 9Start Page: 941End Page: 945Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.228Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.228Citation Count: 140
-
OPENTitle: Lack of significant Lewy pathology in 237 essential tremor brainsJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 82Issue #: 5Start Page: 452End Page: 453Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/jnen/nlad022Best OA location URL: https://doi.org/10.1093/jnen/nlad022Citation Count: 4
-
OPENTitle: Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's diseaseJournal Name: Brain StimulationPublisher: Elsevier BVVol: 11Issue #: 6Start Page: 1404End Page: 1406Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2018.08.016Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X18302997/pdfCitation Count: 9
- Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic mice2021OPENTitle: Nurr1 repression mediates cardinal features of Parkinson’s disease in α-synuclein transgenic miceJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 30Issue #: 16Start Page: 1469End Page: 1483Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab118Best OA location URL: https://academic.oup.com/hmg/article-pdf/30/16/1469/39351981/ddab118.pdfCitation Count: 18
-
OPENTitle: Environmental Risk Factors for Progressive Supranuclear PalsyJournal Name: Journal of Movement DisordersPublisher: The Korean Movement Disorder SocietyVol: 14Issue #: 2Start Page: 103End Page: 113Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.14802/jmd.20173Best OA location URL: https://doi.org/10.14802/jmd.20173Citation Count: 28
-
OPENTitle: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3865178Citation Count: 66
-
OPENTitle: A comparative study of Lrrk2 function in primary neuronal culturesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 16Issue #: 10Start Page: 650End Page: 655Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2010.08.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3159957Citation Count: 78
-
OPENTitle: Chronic exposure to dopamine agonists affects the integrity of striatal D2 receptors in Parkinson's patientsJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 455End Page: 460Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.013Best OA location URL: https://doi.org/10.1016/j.nicl.2017.08.013Citation Count: 35
- Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled Trial2014OPENTitle: Effects of Tyrosine on Parkinson's Disease: A Randomized, Double‐Blind, Placebo‐Controlled TrialJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 1Issue #: 4Start Page: 348End Page: 353Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12082Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12082Citation Count: 16
- LRRK2 deficiency impacts ceramide metabolism in brain2016OPENTitle: LRRK2 deficiency impacts ceramide metabolism in brainJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 478Issue #: 3Start Page: 1141End Page: 1146Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bbrc.2016.08.082Citation Count: 64
-
OPENTitle: The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 308Issue #:Start Page: 111End Page: 119Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7404626Citation Count: 44
-
OPENTitle: Non-Motor Symptoms as Markers of Disease Severity in Parkinson’s Disease: Associations Between Constipation, Depression, REM Sleep Behavior Disorder, and Motor ImpairmentJournal Name: BiomedicinesPublisher: MDPI AGVol: 13Issue #: 11Start Page: 2704End Page: 2704Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines13112704Best OA location URL: https://www.mdpi.com/2227-9059/13/11/2704/pdf?version=1762184201Citation Count: 0
-
OPENTitle: Autophagy and mitophagy at the synapse and beyond: implications for learning, memory and neurological disordersJournal Name: AutophagyPublisher: Informa UK LimitedVol: 22Issue #: 1Start Page: 10End Page: 52Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2025.2581217Best OA location URL: https://doi.org/10.1080/15548627.2025.2581217Citation Count: 6
-
OPENTitle: In Silico Labeling: Predicting Fluorescent Labels in Unlabeled ImagesJournal Name: CellPublisher: Elsevier BVVol: 173Issue #: 3Start Page: 792End Page: 803.e19Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2018.03.040Best OA location URL: http://www.cell.com/article/S0092867418303647/pdfCitation Count: 679
-
OPENTitle: Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJournal Name: eBioMedicinePublisher: Elsevier BVVol: 80Issue #:Start Page: 104021End Page: 104021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104021Best OA location URL: http://www.thelancet.com/article/S2352396422002055/pdfCitation Count: 85
-
OPENTitle: Intermediate Deformable Image Registration Via Windowed Cross-CorrelationJournal Name: 2023 IEEE 20th International Symposium on Biomedical Imaging (ISBI)Publisher: IEEEVol:Issue #:Start Page: 1End Page: 5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/isbi53787.2023.10230715Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10485808/pdf/nihms-1872292.pdfCitation Count: 2
-
OPENTitle: Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 139Issue #:Start Page: 104810End Page: 104810Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104810Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104810Citation Count: 38